Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Return on Invested Capital (2024 - 2025)

Historic Return on Invested Capital for Inhibrx Biosciences (INBX) over the last 2 years, with Q3 2025 value amounting to 1.01%.

  • Inhibrx Biosciences' Return on Invested Capital rose 8500.0% to 1.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.01%, marking a year-over-year increase of 8500.0%. This contributed to the annual value of 3.74% for FY2024, which is N/A changed from last year.
  • Inhibrx Biosciences' Return on Invested Capital amounted to 1.01% in Q3 2025, which was up 8500.0% from 0.93% recorded in Q2 2025.
  • Inhibrx Biosciences' 5-year Return on Invested Capital high stood at 0.93% for Q2 2025, and its period low was 2.12% during Q4 2024.